VIVUS Aktie - VVUS

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,4665

Gebot

0,4625

Fragen

0,4626

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,4665

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

VIVUS Receives Court Approval of Joint Chapter 11 Plan of Reorganization

CAMPBELL, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (the “Company”), a biopharmaceutical company...

VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Dat...

CAMPBELL, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- On November 10, 2020, VIVUS, Inc. (the “Company”), a...

VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC

CAMPBELL, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a...

VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.

CAMPBELL, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a...

VIVUS Reports First Quarter 2020 Financial Results

Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS...

VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020

CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will...

VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt...

CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a...

VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

CAMPBELL, Calif., April 03, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a...

VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules

VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring...

VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

CAMPBELL, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

VVUS - Frequently Asked Questions (FAQ)

What is the current VIVUS share price?

The current share price of VIVUS is US$ 0,4665

What is the 1 year trading range for VIVUS share price?

VIVUS has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GVVisionary Holdings Inc	US$ 2,30 (78,29%)	78,74M
CMRXChimerix Inc	US$ 8,405 (69,46%)	92,64M
ARBBARB IOT Group Ltd	US$ 0,792651 (52,43%)	52,26M
CDXCChromaDex Corporation	US$ 8,4986 (51,76%)	6,31M
PRTSCarParts com Inc	US$ 1,215 (37,88%)	4,25M
CUTRCutera Inc	US$ 0,1666 (-47,01%)	5,71M
LBGJLi Bang International Corporation Inc	US$ 1,30 (-35,00%)	114,77k
XCURExicure Inc	US$ 10,515 (-26,37%)	65,75k
CRWLGranite Shares 2x Long CRWD Daily ETF	US$ 22,90 (-21,06%)	276,91k
TIVCTivic Health Systems Inc	US$ 0,2741 (-19,36%)	796,03k
ADTXAditxt Inc	US$ 0,055 (10,44%)	101,65M
CMRXChimerix Inc	US$ 8,41 (69,56%)	93,88M
GVVisionary Holdings Inc	US$ 2,2901 (77,53%)	82,22M
NVDANVIDIA Corporation	US$ 115,54 (-0,39%)	73,88M
SLXNSilexion Therapeutics Corporation	US$ 1,425 (28,38%)	70,72M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

VIVUS Inc (VVUS)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

VVUS Neueste Nachrichten

VIVUS Receives Court Approval of Joint Chapter 11 Plan of Reorganization

VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Dat...

VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC

VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.

VIVUS Reports First Quarter 2020 Financial Results

VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020

VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt...

VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules

VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

VVUS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

VIVUS Inc (VVUS) Börsenkurse

VIVUS Inc (VVUS)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

VVUS Neueste Nachrichten

VIVUS Receives Court Approval of Joint Chapter 11 Plan of Reorganization

VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Dat...

VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC

VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.

VIVUS Reports First Quarter 2020 Financial Results

VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020

VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt...

VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules

VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

VVUS - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS